Global Medical Bed Market Size (By Type: Electric Bed, Semi Electric Bed, Manual Bed; By Application: Outpatient Clinics, Medical Nursing Homes, Medical Laboratory and Research; By Usage: Acute Care, Long Term Care, Psychiatric Care, Maternity) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033

The global medical bed market size was exhibited at USD 3.39 billion in 2023 and is projected to hit around USD 6.19 billion by 2033, growing at a CAGR of 6.2% during the forecast period of 2024 to 2033.

Medical Bed Market Size 2024 To 2033

Key Takeaways:

  • According to estimates, the electric bed market would see the greatest CAGR between 2023 and 2033.
  • These beds allowed medical workers to provide patients with greater comfort without having to elevate them. 
  • Over the course of the projection, North America is anticipated to hold a sizable portion of the market.

Medical Bed Market Report Scope

 Report Coverage  Details
Market Size in 2024 USD 3.39 Billion
Market Size by 2033 USD 6.19 Billion
Growth Rate From 2024 to 2033 CAGR of 6.2%
Base Year 2023
Forecast Period 2024-2033
Segments Covered By Type, By Application, By Usage
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional Scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Invacare Corporation., Hill-Rom Services, Inc., Stryker Corporation, Medical Depot, Inc., Gendron Inc., Arjo., HARD Manufacturing Company, Inc., GF Health Products, Inc., Transfer Master Products, Inc., Umano Medical inc., ProBed Medical Technologies, American Medical Equipment, Getinge AB., Amico Group of Companies., Merivaara, ANTANO GROUP, LINET., Stiegelmeyer GmbH & Co. KG, Mobility Aids Sales and Services, PARAMOUNT BED CO., LTD. and Others.

 

Medical beds, which range from manually controlled to fully electric, guarantee the patients' comfort while also having cutting-edge features. Additionally, it is projected that the market would rise as a result of healthcare providers' increasing expenditures on hospital infrastructure and patients' access to affordable treatment worldwide. The market is anticipated to increase as a result of factors like the expanding geriatric population and the prevalence of chronic illnesses worldwide. Over the projected period, the market for medical beds is expected to expand at a CAGR of almost 5.8%.

Furthermore, throughout the course of the forecast period, the market is anticipated to rise as a result of technical advancements, the adoption of medical beds, and an increase in the number of hospitals. However, it is projected that the market expansion would be hampered by the high cost of medical beds and a decline in the number of beds in public hospitals.

Growth Factors

Medical beds are the equipment used in hospitals for patients who are bedridden or in need of care. Medical beds make it easier to transfer patients, improve patient placement, and reduce the chance that they may roll out of bed.

Patient beds known as manual medical beds are those that can be adjusted manually for the comfort of the patient. Manual medical beds are predicted to support the segment's growth throughout the forecast period because they are less likely to have a motor failure, are less expensive, and have simple operating mechanisms. Due to rising expenditures on hospital infrastructure and an increase in the number of organized hospitals throughout the world, the electric bed market is predicted to develop at a substantial rate.

According to the World Population Ageing Report, the proportion of elder people worldwide, which was about 89.3% in 2020, may rise to 16% by 2050. Furthermore, it is predicted that the market would increase during the forecast period due to the rising elderly population and lifestyle illnesses that require medical beds for better treatment and comfort.

According to the end user, the homecare sector is expected to see rapid market expansion due to the use of medical beds in homecare settings and the rising number of diabetes patients worldwide.

Key Market Drivers

  • The frequency of chronic illnesses is increasing - The frequency of chronic illnesses is increasing, and consumers are becoming more interested in hospital beds that are well-equipped with cutting-edge features. Additionally, postoperative care and home healthcare services for the elderly population provide market participants with significant potential.
  • The National Health Council research estimates that 40 million Americans experience limitations in their daily activities as a result of one or more chronic health issues. According to a survey released in 2019, 133 million Americans or more than 40% of the population have incurable chronic conditions. Many people struggle not just with one but with two or more chronic ailments, such as diabetes, heart disease, or depression. The demand for hospital beds is fueled by the possibility that a high incidence of chronic illnesses may increase the need for hospitalization.
  • 80% of general practitioner (GP) consultations and 60% of hospital bed requirements, according to estimates in a study by the Department of Health & Children, are connected to cases of chronic diseases with accompanying problems. Acute care hospital beds are accessible for curative care, with 100,000 beds per population in Europe, according to research by the Data and Digital Health Unit. These beds can accommodate patients for a variety of medical procedures, including conducting operations, treating non-mental disease symptoms, managing labor (obstetrics), healing non-mental sicknesses or offering conclusive therapies for injuries, and more. Every year in the US, addressing chronic illnesses receives around 75% of healthcare spending. 8 of the top 11 reasons for hospitalization in the UK, as estimated by the Department of Health & Children report, are related to chronic diseases, and 5% of inpatients have long-term disorders, occupying 42% of hospital beds.
  • Diabetes and heart diseases, among other chronic conditions - The major causes of mortality and disability in the US are chronic disorders like diabetes and heart disease. For instance, the most prevalent chronic illnesses affecting more than one in four persons in California in 2019 were high blood pressure and obesity. Additionally, there were 700 hospitalizations per 100,000 persons in California among those with chronic diseases, representing high hospital admission rates. As a result, the worldwide market for medical beds is expanding overall because of the rising frequency of chronic illnesses. 

Key Market Challenges 

  • The growing cost of specialty beds - The predicted expansion of the medical bed market in the target period is further expected to be hampered by the rising cost of specialty beds. The future expansion of the medical bed market, however, may be further hampered by the fall in the number of hospital beds in developed nations.

Key Market Opportunities

  • The ongoing COVID-19 pandemic has shown a positive impact on the medical bed industry - Additionally, Positive effects on the hospital bed sector have been seen as a result of the ongoing COVID-19 outbreak. The main cause of the rising need for these beds is the expanding population of COVID-19 patients throughout the world. In addition, businesses are introducing new items to suit the need on a global scale. For instance; the Stryker Corporation issued emergency relief beds in April 2020 to help hospitals that were in need of beds during the COVID-19 epidemic. 

Segments Insight

Type Insights

Semi-electric, electric, and manual medical beds are the three main types available on the market today. According to estimates, the electric bed market would see the greatest CAGR between 2023 and 2033. Electric beds are rapidly expanding in popularity. Additionally, these beds provide a remote-controlled therapeutic massage option for patients who are confined to their beds. This function promotes blood flow and guards against bedsores and joint discomfort. The functionality is activated by default in the mattress. Additionally, neither the patients nor the caretakers need to worry about losing support in the middle of the night or make frequent modifications. The M9 set of beds from Taranaki-based medical bed manufacturer Howard Wright was bought by Hwera Hospital in August 2023.

These beds allowed medical workers to provide patients with greater comfort without having to elevate them. The complete electric controls on the M9 beds allow for full height and position adjustment. Other electric hospital beds on the market include the Zenith9100, the Invacare Full-Electric Homecare Bed, and the DELTA 4 series.

Application Insights

These beds allowed medical workers to provide patients with greater comfort without having to elevate them. The complete electric controls on the M9 beds allow for full height and position adjustment. Other electric hospital beds on the market include the Zenith9100, the Invacare Full-Electric Homecare Bed, and the DELTA 4 series. The Global Cancer Observatory estimates that 19.3 million new cancer cases will be diagnosed globally in 2020, indicating an increase in the incidence of the disease worldwide. Due to its ability to improve nurse workflow efficiency and shorten total in-patient stays, smart hospital beds are predicted to continue to be in high demand.

From 2023 to 2033, the outpatient clinics market is anticipated to grow at a revenue-based CAGR of 7.3%. The expansions of primary healthcare institutions and, as a result, their predominance in rural areas throughout Asia, Africa, and South America have been directly related to improvements in healthcare standards in these nations. The primary diagnostic and first point of care for patients worldwide is provided via outpatient clinics. In addition, the incidence of acute illnesses like the flu, fevers, and bronchitis has been a major role in encouraging people all over the world to visit outpatient clinics. The World Health Organization (WHO) reports that the number of outpatient interactions per person in Europe ranged from 1.9 to 13.1 in 2011 before peaking at 2.6 to 13.5 in 2018.

Regional Insights

Over the course of the projection, North America is anticipated to hold a sizable portion of the market. The existence of major market participants, the rising incidence of diabetes, and the well-established healthcare infrastructure are all factors in the market expansion. In addition, it is projected that the region's rising incidence of cancer and other chronic illnesses would spur market expansion. In the United States, there were 1,762,450 new cases of cancer in 2019, according to the National Institute for Health. Because of the region's growing number of hospitals and rising healthcare infrastructure, the Asia-Pacific is expected to experience significant market expansion. Additionally, it is projected that rising hospitalization rates and the burden of sickness in developing nations would promote market expansion.

The highest market share for hospital beds worldwide is held by Europe. Germany has the most hospital beds among the EU members, along with significant income and expansion. Germany has the most ICU beds, according to the most recent OECD 2020 statistics. Germany had 28,000 intensive care beds when the epidemic began, which is higher than most of its neighbors. As of April 18, 2020, 12,336 ICU beds or 41% of the country's total capacity remained unoccupied during the first SARS-CoV-2 pandemic wave. The German government prioritized primary and secondary prevention in order to deal with this health problem, and as a tertiary preventative step, more beds were added to the ICU's current capacity. As of April 27, 2020, the German government added 7,000 beds. With the increase in operations, particularly cardiac, orthopedic, and trauma surgery, the UK hospital bed market is anticipated to expand.

Recent Developments

  • March 2022: In order to assist with the COVID-19 response, Hill-Rom said that the manufacturing of items of critical care, such as med-surg unit smart hospital beds and ICU, will be increased.
  • August 2021: A medical bed brand called NordBed was launched by Invacare Corporation to support people with limited mobility and aging-related health conditions. This tactical choice led to an expansion of the company's medical bed product line.

Some of the prominent players in the medical bed market include:

  • Invacare Corporation. (US)
  • Hill-Rom Services, Inc. (US)
  • Stryker Corporation (US)
  • Medical Depot, Inc. (Canada)
  • Gendron Inc. (US)
  • Arjo. (Sweden)
  • HARD Manufacturing Company, Inc. (US)
  • GF Health Products, Inc. (US)
  • Transfer Master Products, Inc. (US)
  • Umano Medical inc. (Canada)
  • ProBed Medical Technologies (Canada)
  • American Medical Equipment. (US)
  • Getinge AB. (Sweden)
  • Amico Group of Companies. (US)
  • Merivaara (Finland)
  • ANTANO GROUP (Italy)
  • LINET. (Czechia)
  • Stiegelmeyer GmbH & Co. KG (Germany)
  • Mobility Aids Sales and Services (India)
  • PARAMOUNT BED CO., LTD. (Japan)

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global medical bed market.

By Type

  • Electric Bed
  • Semi Electric Bed
  • Manual Bed

By Application

  • Outpatient Clinics
  • Medical Nursing Homes
  • Medical Laboratory and Research

By Usage

  • Acute Care
  • Long Term Care
  • Psychiatric Care
  • Maternity

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global medical bed market size was exhibited at USD 3.39 billion in 2023 and is projected to hit around USD 6.19 billion by 2033

The global medical bed market is poised to grow at a CAGR of 6.2% from 2023 to 2032.

The major players operating in the medical bed market are Invacare Corporation., Hill-Rom Services, Inc., Stryker Corporation, Medical Depot, Inc., Gendron Inc., Arjo., HARD Manufacturing Company, Inc., GF Health Products, Inc., Transfer Master Products, Inc., Umano Medical inc., ProBed Medical Technologies, American Medical Equipment, Getinge AB., Amico Group of Companies., Merivaara, ANTANO GROUP, LINET., Stiegelmeyer GmbH & Co. KG, Mobility Aids Sales and Services, PARAMOUNT BED CO., LTD. and Others.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Bed Market 

5.1. COVID-19 Landscape: Medical Bed Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Bed Market, By Type

8.1. Medical Bed Market, by Type, 2024-2033

8.1.1 Electric Bed

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Semi Electric Bed

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Manual Bed

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Medical Bed Market, By Application

9.1. Medical Bed Market, by Application, 2024-2033

9.1.1. Outpatient Clinics

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Medical Nursing Homes

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Medical Laboratory and Research

9.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Medical Bed Market, By Usage 

10.1. Medical Bed Market, by Usage, 2024-2033

10.1.1. Acute Care

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Long Term Care

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Psychiatric Care

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Maternity

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Medical Bed Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Forecast, by Usage (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Forecast, by Usage (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Forecast, by Usage (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Forecast, by Usage (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Forecast, by Usage (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Forecast, by Usage (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Forecast, by Usage (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Forecast, by Usage (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Forecast, by Usage (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Forecast, by Usage (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Forecast, by Usage (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Forecast, by Usage (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Forecast, by Usage (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Forecast, by Usage (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Forecast, by Usage (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Forecast, by Usage (2021-2033)

Chapter 12. Company Profiles

12.1. Invacare Corporation. (US)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Hill-Rom Services, Inc. (US)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Stryker Corporation (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Medical Depot, Inc. (Canada)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Gendron Inc. (US)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Arjo. (Sweden)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. HARD Manufacturing Company, Inc. (US)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. GF Health Products, Inc. (US)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Transfer Master Products, Inc. (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Umano Medical inc. (Canada)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

 

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers